<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" 
        xmlns:image="http://www.google.com/schemas/sitemap-image/1.1">
  <url>
    <loc>https://openbell.ai/</loc>
    <lastmod>2026-10-20T13:27:37.330Z</lastmod>
    <changefreq>hourly</changefreq>
    <priority>1.0</priority>
  </url>
  <url>
    <loc>https://openbell.ai/support</loc>
    <lastmod>2026-10-20T13:27:37.330Z</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.7</priority>
  </url>
  <url>
    <loc>https://openbell.ai/privacy</loc>
    <lastmod>2026-10-20T13:27:37.330Z</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://openbell.ai/terms</loc>
    <lastmod>2026-10-20T13:27:37.330Z</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://openbell.ai/feed.json</loc>
    <lastmod>2026-10-20T13:27:37.330Z</lastmod>
    <changefreq>hourly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://openbell.ai/news/NNN:1792502803285</loc>
    <lastmod>2026-10-20T13:26:43.285Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/NNN/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Barclays Maintains Underweight on NNN REIT, Lowers Price Target to $43</image:title>
      <image:caption>Barclays analyst Richard Hightower has maintained an Underweight rating on NNN REIT (NYSE: NNN) and has reduced the price target from $47 to $43.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/CRM:1792502615501</loc>
    <lastmod>2026-10-20T13:23:35.501Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/CRM/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Salesforce Bets $5.7 Billion on AI Marketing With Braze Acquisition</image:title>
      <image:caption>Salesforce Inc. has announced its acquisition of Braze Inc. for approximately $5.66 billion, aimed at enhancing its artificial intelligence and customer engagement capabilities. Following the announcement, Braze&#39;s stock surged over 51%, while Salesforce&#39;s shares fell by 2.98%. Braze, which serves around 2,770 customers, will receive $47.50 per share in cash, and the deal is expected to close in fiscal 2028, pending regulatory approvals. Salesforce has raised its fiscal 2027 revenue forecast to $46.4 billion, exceeding analyst estimates.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/HAL:1792502545530</loc>
    <lastmod>2026-10-20T13:22:25.530Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/HAL/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Halliburton Sees Solid Growth In Venezuela Going Forward; Expects Q4 Earnings Per Share To Be About $0.62 - $0.64</image:title>
      <image:caption>Halliburton (HAL) anticipates strong growth in Venezuela and projects its Q4 earnings per share to be between $0.62 and $0.64. This outlook reflects the company&#39;s confidence in its operations and market conditions in the region.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/EYPT:1792502437696</loc>
    <lastmod>2026-10-20T13:20:37.696Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/EYPT/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>RBC Capital Maintains Sector Perform on EyePoint, Lowers Price Target to $1</image:title>
      <image:caption>RBC Capital analyst Lisa Walter has maintained a &#39;Sector Perform&#39; rating on EyePoint Pharmaceuticals (NASDAQ:EYPT) while lowering the price target from $5 to $1. This adjustment reflects a significant reduction in expectations for the company&#39;s stock performance.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/HAL:1792502354040</loc>
    <lastmod>2026-10-20T13:19:14.040Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/HAL/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Halliburton Expects About 12% YoY Growth In International Revenue Outside Middle East In 2026</image:title>
      <image:caption>Halliburton anticipates approximately 12% year-over-year growth in its international revenue, excluding the Middle East, by 2026. This projection indicates a positive outlook for the company&#39;s performance in global markets. The stock ticker for Halliburton is HAL.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/CELZ:1792502334937</loc>
    <lastmod>2026-10-20T13:18:54.937Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/CELZ/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Creative Medical Technology Highlights Ultrasome Data Showing 93% Response Rate, 65% Pain Reduction In Knee Osteoarthritis Study</image:title>
      <image:caption>Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ) reported positive results from a study on its Ultrasome™ platform, showing a 93% response rate in 30 patients with knee osteoarthritis, with an average pain reduction of approximately 65% over six months. Additionally, the average WOMAC score, reflecting pain and physical limitations, decreased by 52%, and quality of life scores improved significantly. No serious adverse events were reported during the study, which supports further development of the Ultrasome™ platform as a scalable cell-free regenerative medicine opportunity.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/MMM:1792502282437</loc>
    <lastmod>2026-10-20T13:18:02.437Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/MMM/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>3M CEO Says Closed 16 Manufacturing Sites, Distribution Centers YTD; Taking Action On 10 More Over Next 12 Months</image:title>
      <image:caption>3M&#39;s CEO announced the closure of 16 manufacturing sites and distribution centers year-to-date, with plans to take action on an additional 10 sites over the next 12 months. This strategic move is part of the company&#39;s efforts to streamline operations and improve efficiency. The announcement was made during a recent conference call.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/OMC:1792502070316</loc>
    <lastmod>2026-10-20T13:14:30.316Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/OMC/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Omnicom&amp;#39;s Credera Inks Five-Year Parntership With Amazon Web Services For Marketing Transformation, Upgrade Of Infrastructure, Deploy AI Into Production</image:title>
      <image:caption>Credera, a consulting firm under Omnicom (NYSE: OMC), has entered into a five-year strategic collaboration agreement with Amazon Web Services (AWS). This partnership aims to accelerate marketing transformation, modernize infrastructure, and deploy AI solutions for clients, leveraging Credera&#39;s technical capabilities and Omnicom&#39;s client relationships. The solutions developed will integrate with Omni, Omnicom&#39;s AI-powered marketing and sales intelligence platform.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/FLUT:1792502062392</loc>
    <lastmod>2026-10-20T13:14:22.392Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/FLUT/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Flutter Entertainment Enters Restructuring Plan For Its UK &amp;amp; Ireland Operations With Headcount Reduction Of Up To 1.4K And Aggregate Pre-Tax Charges Of ~$80M-$90M</image:title>
      <image:caption>Flutter Entertainment plc has announced a restructuring plan for its UK and Ireland operations, which will involve a headcount reduction of up to 1,400 employees. The company anticipates incurring pre-tax charges of approximately $80 to $90 million, primarily related to employee severance and benefits. This restructuring is part of Flutter&#39;s strategy to address the impact of rising UK gaming taxes and is expected to be largely completed by the end of 2026.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/BULL:1792502023009</loc>
    <lastmod>2026-10-20T13:13:43.009Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/BULL/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Webull Says Perpetual Futures To Be Listed On KalshiEX And Cleared Through Kalshi Klear; Perpetual Futures Broader Availability Expected Before Year-End</image:title>
      <image:caption>Webull (NASDAQ: BULL) announced that it will begin offering perpetual futures, including Bitcoin and select crypto assets, to eligible U.S. customers starting in November 2026. This move aims to expand its derivatives offerings through a regulated platform, allowing traders to maintain continuous exposure to underlying assets without fixed expiration dates. Broader availability of perpetual futures is expected before the end of the year.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/HTZ:1792501995826</loc>
    <lastmod>2026-10-20T13:13:15.826Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.benzinga.com/files/images/story/2026/10/20/HertzSaint-Priest--France---June-18--201.jpg?width=250&amp;height=187</image:loc>
      <image:title>Hertz Stock Rises After Oro Mobility Raises $80 Million for Autonomous Fleet Expansion</image:title>
      <image:caption>Hertz Global Holdings Inc. (NASDAQ: HTZ) shares rose 13.05% to $2.08 following the announcement that its majority-owned subsidiary, Oro Mobility, secured an $80 million strategic equity investment from a consortium including Cohen Private Ventures and Certares Opportunities. This investment will enable Oro to operate as a stand-alone platform, expanding its fleet of approximately 45,000 vehicles and enhancing its operational infrastructure and technology. Hertz will maintain majority economic ownership and continue to support Oro as a partner in its growth.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/BULL:1792501906069</loc>
    <lastmod>2026-10-20T13:11:46.069Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/BULL/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>&amp;#39;Webull to Offer Perpetual Futures Starting Next Month&amp;#39; - The Wall Street Journal</image:title>
      <image:caption>Webull is set to launch perpetual futures trading starting next month, expanding its offerings in the financial markets. This move aims to attract more traders and enhance user engagement on its platform. The introduction of perpetual futures is expected to position Webull competitively within the trading industry.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/TSM:1792501858499</loc>
    <lastmod>2026-10-20T13:10:58.499Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/TSM/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Taiwan Semiconductor Manufacturing Halts Construction At Kaohsiung Plant Due To Accident At Construction Process Of Steel Structure Operation</image:title>
      <image:caption>Taiwan Semiconductor Manufacturing Company (TSMC) has halted construction at its Kaohsiung plant following an accident during the steel structure operation. The incident has raised safety concerns, prompting the company to pause work to assess the situation. No financial figures or impacts on stock prices were mentioned in the article.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/GM:1792501844937</loc>
    <lastmod>2026-10-20T13:10:44.937Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.benzinga.com/files/images/story/2026/10/20/Marion---Circa-October-2021-General-Moto.jpg?width=250&amp;height=187</image:loc>
      <image:title>General Motors Profit Outlook Disappoints, Stock Sinks</image:title>
      <image:caption>General Motors Co. (NYSE: GM) reported third-quarter revenue of $50.015 billion, a 2.9% increase year-over-year, surpassing analyst expectations, with adjusted earnings rising 32.2% to $3.70 per share. However, the company narrowed its 2026 adjusted profit outlook to $12.75 to $13.75 per share, below Wall Street estimates, leading to a 7% decline in stock price during premarket trading. Despite strong demand for pickup trucks and SUVs, concerns over rising costs impacted investor sentiment, while the company announced a new $20 billion share repurchase program and declared a quarterly dividend of 18 cents per share.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/GOOGL:1792501781219</loc>
    <lastmod>2026-10-20T13:09:41.219Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/GOOGL/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>&amp;#39;Waymo Plans To Quintuple Its Fleet&amp;#39; - Semafor Exclusive</image:title>
      <image:caption>Waymo, a subsidiary of Alphabet Inc. (GOOGL), plans to quintuple its fleet of autonomous vehicles as part of its expansion strategy. The company aims to significantly increase its operational capacity to meet growing demand for self-driving technology. This strategic move is expected to enhance Waymo&#39;s competitive position in the autonomous vehicle market.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/COR:1792501748575</loc>
    <lastmod>2026-10-20T13:09:08.575Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/COR/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Argus Research Maintains Buy on Cencora, Raises Price Target to $380</image:title>
      <image:caption>Argus Research analyst David Toung has maintained a &#39;Buy&#39; rating on Cencora (NYSE: COR) and increased the price target from $340 to $380. This adjustment reflects a positive outlook on the company&#39;s performance.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/PRSO:1792501732830</loc>
    <lastmod>2026-10-20T13:08:52.830Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/PRSO/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Peraso Awarded $2M Production Order To Deploy Fixed Wireless Access Systems Utilizing Its 60 GHz Technology</image:title>
      <image:caption>Peraso Inc. (NASDAQ: PRSO) has secured a production order exceeding $2 million from a prominent network equipment manufacturer. This order is for the deployment of fixed wireless access systems that utilize Peraso&#39;s 60 GHz technology.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/AMGN:1792501618799</loc>
    <lastmod>2026-10-20T13:06:58.799Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/AMGN/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Amgen, AstraZeneca Announces Data From Phase 3 CROSSING Study Demonstrated TEZSPIRE Showed Histologic Remission For 64.8% For 210 Mg Dose At Week 24; TEZSPIRE Also Reduced Frequency, Severity Of Dysphagia Symptoms 18.8 Points</image:title>
      <image:caption>Amgen (NASDAQ: AMGN) and AstraZeneca announced positive results from the Phase 3 CROSSING trial for TEZSPIRE (tezepelumab-ekko), showing histologic remission in 64.8% of patients at the 210 mg dose and 68.9% at the 420 mg dose at week 24, compared to 3.5% for placebo (p&lt;0.001). Additionally, TEZSPIRE reduced dysphagia symptoms by 18.8 points for the 210 mg dose and 22.0 points for the 420 mg dose, significantly outperforming the placebo group. These improvements were sustained through week 52 for patients with symptomatic and uncontrolled eosinophilic esophagitis.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/RGLD:1792501604321</loc>
    <lastmod>2026-10-20T13:06:44.321Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/RGLD/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Royal Gold Reports Preliminary Q3 Stream Segment Sales Of $318.3M And Royalty Segment Sales Of $143M-$149M</image:title>
      <image:caption>openbell Financial News</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/HTLD:1792501591217</loc>
    <lastmod>2026-10-20T13:06:31.217Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/HTLD/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Heartland Express Q3 EPS $0.01 Misses $0.04 Estimate, Sales $179.504M Miss $188.365M Estimate</image:title>
      <image:caption>Heartland Express (NASDAQ: HTLD) reported Q3 earnings of $0.01 per share, missing the analyst estimate of $0.04 by 75%. This marks a significant improvement from a loss of $(0.11) per share in the same quarter last year. The company&#39;s sales totaled $179.504 million, falling short of the $188.365 million estimate by 4.70% and representing an 8.67% decrease from $196.547 million in the previous year.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/AMGN:1792501581707</loc>
    <lastmod>2026-10-20T13:06:21.707Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/AMGN/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>AstraZeneca And Amgen&amp;#39;s TEZSPIRE Met Co-Primary Endpoints In Phase III EoE Trial</image:title>
      <image:caption>AstraZeneca and Amgen&#39;s TEZSPIRE (tezepelumab) met co-primary endpoints in the Phase III CROSSING trial for eosinophilic esophagitis (EoE), achieving statistically significant histologic remission and symptom improvements at week 24, sustained through week 52. At week 24, 64.8% of patients on the 210mg dose and 68.9% on the 420mg dose achieved histologic remission compared to 3.5% on placebo. Additionally, TEZSPIRE reduced dysphagia symptoms significantly, with improvements of 18.8 points and 22.0 points for the respective doses, compared to 14.7 points on placebo. The trial results were presented at the United European Gastroenterology Week 2026 in Barcelona.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/BRZE:1792501571228</loc>
    <lastmod>2026-10-20T13:06:11.228Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/BRZE/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Braze shares are trading higher after the announcement that company will be acquired by Salesforce.</image:title>
      <image:caption>openbell Financial News</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/WSM:1792501525914</loc>
    <lastmod>2026-10-20T13:05:25.914Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/WSM/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Piper Sandler Maintains Overweight on Williams-Sonoma, Raises Price Target to $286</image:title>
      <image:caption>Piper Sandler analyst Peter Keith has maintained an Overweight rating on Williams-Sonoma (NYSE: WSM) and increased the price target from $259 to $286. This adjustment reflects a positive outlook for the company&#39;s performance in the market.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/CSAI:1792501510894</loc>
    <lastmod>2026-10-20T13:05:10.894Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/CSAI/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Cloudastructure Launches Configurable Powered Enclosure, Completing Four-Product AI Surveillance Portfolio For Remote And Infrastructure-Limited Sites</image:title>
      <image:caption>Cloudastructure, Inc. (NASDAQ: CSAI) has launched its fully configurable Powered Enclosure, completing its four-product AI surveillance portfolio aimed at remote and infrastructure-limited sites. This new offering allows for customizable camera configurations and power sources, supporting up to four PoE+ cameras with options for solar, generator, and utility power. The system is designed for diverse environments, featuring a robust battery and multiple connectivity solutions, enabling customers to manage all surveillance deployments through a unified cloud-native platform.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/PEN:1792501468001</loc>
    <lastmod>2026-10-20T13:04:28.001Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/PEN/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Penumbra Wins FDA Clearance For Lightning CAVT Technology To Treat Deep Vein Thrombosis, Backed By BOLT-DVT Trial Results</image:title>
      <image:caption>Penumbra, Inc. has received FDA clearance for its Lightning computer assisted vacuum thrombectomy (CAVT) technology to treat deep vein thrombosis (DVT). This approval is based on positive results from the BOLT-DVT trial, which confirmed the safety and efficacy of CAVT for DVT treatment. The company is recognized as a leader in thrombectomy solutions.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/AVGO:1792501454965</loc>
    <lastmod>2026-10-20T13:04:14.965Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/AVGO/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>FedEx To Continue Utilizing Broadcom&amp;#39;s Infrastructure Software Portfolio Under Expanded Collaboration</image:title>
      <image:caption>Broadcom Inc. has announced the continuation of its collaboration with FedEx Corp. under a consolidated agreement aimed at optimizing FedEx&#39;s digital infrastructure and application modernization. FedEx will utilize Broadcom&#39;s infrastructure software portfolio, including VMware Cloud Foundation, VMware Avi Load Balancer, and VMware Tanzu Platform, to support its technology operations. This partnership is expected to enhance FedEx&#39;s ability to deliver efficient global services.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/LIQT:1792501434206</loc>
    <lastmod>2026-10-20T13:03:54.206Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/LIQT/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>LiqTech Secures Order From Shanghai Qiyao For Two Water Treatment Units For iCER Marine Engine Applications With Delivery Scheduled For December 2026</image:title>
      <image:caption>LiqTech International, Inc. has secured an order from Shanghai Qiyao Environmental Technology Co. Ltd. for two water treatment units designed for intelligent control by exhaust recycling (iCER) marine engine applications, with delivery scheduled for December 2026. This order represents Shanghai Qiyao&#39;s first purchase of LiqTech&#39;s iCER systems and builds on their existing relationship focused on marine scrubber water treatment. The announcement follows a series of recent marine orders by LiqTech since establishing a joint venture in China in November 2024.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/OMDA:1792501339178</loc>
    <lastmod>2026-10-20T13:02:19.178Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/OMDA/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Omada Health To Present Published Research Showing That Members Of Its GLP-1 Care Track Lost More Weight And Experienced Greater Improvements In Body Composition Than GLP-1 Users Receiving Usual Care</image:title>
      <image:caption>Omada Health&#39;s research indicates that participants in its GLP-1 Care Track program lost an average of 6.0% of their starting body weight, compared to 3.3% for those receiving usual care. Additionally, Omada members reduced their body fat percentage by 3.3% and increased muscle mass by 0.6%, while also reporting significant improvements in well-being and a 30% reduction in depression and anxiety symptoms. The study involved 245 adults with obesity, with 151 in the Omada program and 94 in the usual care group.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/HTFL:1792501248008</loc>
    <lastmod>2026-10-20T13:00:48.008Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/HTFL/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Piper Sandler Reiterates Overweight on HeartFlow, Raises Price Target to $64</image:title>
      <image:caption>Piper Sandler analyst Matt O&#39;Brien has reiterated an Overweight rating on HeartFlow (NASDAQ: HTFL) and increased the price target from $45 to $64. This adjustment reflects a positive outlook on the company&#39;s performance.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/NU:1792501170597</loc>
    <lastmod>2026-10-20T12:59:30.597Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/NU/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>UBS Maintains Buy on Nu Holdings, Raises Price Target to $20.5</image:title>
      <image:caption>UBS analyst Thiago Batista has maintained a Buy rating on Nu Holdings (NYSE: NU) and increased the price target from $18.2 to $20.5. This adjustment reflects a positive outlook for the company&#39;s performance in the market.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/PCTY:1792501099925</loc>
    <lastmod>2026-10-20T12:58:19.925Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/PCTY/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Citizens Maintains Market Outperform on Paylocity Holding, Raises Price Target to $180</image:title>
      <image:caption>Citizens analyst Patrick Walravens has maintained a Market Outperform rating on Paylocity Holding (NASDAQ: PCTY) and raised the price target from $150 to $180.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/INTR:1792501055395</loc>
    <lastmod>2026-10-20T12:57:35.395Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/INTR/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>UBS Maintains Buy on Inter &amp;amp; Co, Raises Price Target to $10</image:title>
      <image:caption>UBS has maintained a Buy rating on Inter &amp; Co (NASDAQ: INTR) and increased its price target from $8.8 to $10. This adjustment reflects UBS&#39;s positive outlook on the company&#39;s performance.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/WMT:1792501014392</loc>
    <lastmod>2026-10-20T12:56:54.392Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.benzinga.com/files/images/story/2026/10/20/Walmart.jpg?width=250&amp;height=187</image:loc>
      <image:title>Why Is Walmart Stock in the Spotlight Tuesday?</image:title>
      <image:caption>Walmart Inc. (NYSE: WMT) is in the spotlight due to the introduction of a new $120-a-year membership bundle that combines Walmart+ and Sam’s Club Plus, offering various benefits. Deutsche Bank recently upgraded Walmart to &#39;Buy&#39; from &#39;Hold&#39; and raised its price target from $113 to $136, citing inflation&#39;s impact on the company&#39;s value proposition. Walmart is set to report its third-quarter earnings on November 19, with analysts estimating earnings per share of 64 cents on revenue of $187.33 billion. As of now, Walmart shares are trading 1.50% higher at $120.49.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/KSCP:1792501004579</loc>
    <lastmod>2026-10-20T12:56:44.579Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/KSCP/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Knightscope Reports Q3 Preliminary Revenue Of ~$8.7M, Up 177% YoY; Revenue For Nine Months Totaled ~$23.7M, Up 170% YoY</image:title>
      <image:caption>Knightscope, Inc. (NASDAQ: KSCP) reported preliminary Q3 revenue of approximately $8.7 million, representing a 177% increase year-over-year from $3.1 million in Q3 2025. For the first nine months of 2026, the company achieved total revenue of about $23.7 million, up 170% from $8.8 million during the same period in 2025. This marks the third consecutive quarter of triple-digit year-over-year revenue growth for Knightscope.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/AEP:1792500934031</loc>
    <lastmod>2026-10-20T12:55:34.031Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.benzinga.com/files/images/story/2026/10/20/Stuttgart--Germany---04-27-2023-Cellphon.jpg?width=250&amp;height=187</image:loc>
      <image:title>This American Electric Power Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday</image:title>
      <image:caption>BTIG analyst Alex Kania upgraded American Electric Power Company Inc (NASDAQ:AEP) from Neutral to Buy, setting a new price target of $147, up from its previous closing price of $124.72 on Monday. This upgrade is part of a broader trend, as several analysts have recently adjusted their ratings on various companies, reflecting changes in market outlook.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/CRWV:1792500903414</loc>
    <lastmod>2026-10-20T12:55:03.414Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.benzinga.com/files/images/story/2026/10/20/The-Coreweave-Logo-Appears-On-A-Smartpho.jpg?width=250&amp;height=187</image:loc>
      <image:title>CoreWeave Stock Down 56% From its Peak — HSBC Sees More Pain Ahead</image:title>
      <image:caption>CoreWeave Inc. (NASDAQ: CRWV) shares closed at $61.39, down 56% from its 52-week high of $139.93, with HSBC projecting further declines and maintaining a Reduce rating with a $39 price target, indicating a potential 36.5% downside. The firm estimates CoreWeave will generate about $12 million in annual revenue per megawatt by 2027, significantly lower than the $17 million to $18 million expected for larger hyperscalers. Concerns over financing its AI expansion have led to a 4.16% drop in shares to $58.58 in premarket trading, marking a new 52-week low.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/HTZ:1792500887335</loc>
    <lastmod>2026-10-20T12:54:47.335Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/HTZ/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Hertz Global Holdings shares are trading higher after the company announced that Oro Mobility secured an $80 million strategic equity investment from a consortium of investors.</image:title>
      <image:caption>openbell Financial News</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/CHRD:1792500853138</loc>
    <lastmod>2026-10-20T12:54:13.138Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/CHRD/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>UBS Maintains Buy on Chord Energy, Raises Price Target to $197</image:title>
      <image:caption>UBS analyst Josh Silverstein has maintained a &#39;Buy&#39; rating on Chord Energy (NASDAQ: CHRD) and increased the price target from $193 to $197. This adjustment reflects a positive outlook for the company&#39;s stock performance.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/RTX:1792500786628</loc>
    <lastmod>2026-10-20T12:53:06.628Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/RTX/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>RTX CFO Says FY26 Forecast Raise Includes IEEPA Recovery; Profit Forecast Midpoint Increase Primarily Driven By $0.28 Of Performance Across Co. $0.25 Of IEEPA Recovery</image:title>
      <image:caption>RTX&#39;s CFO announced that the forecast for fiscal year 2026 has been raised, which includes a recovery from the International Emergency Economic Powers Act (IEEPA). The midpoint of the profit forecast has increased primarily due to $0.28 of performance across the company and $0.25 attributed to the IEEPA recovery.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/MYGN:1792500777213</loc>
    <lastmod>2026-10-20T12:52:57.213Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/MYGN/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Myriad Genetics shares are trading higher after the company announced it will sell its Prenatal Health testing business to Labcorp.</image:title>
      <image:caption>openbell Financial News</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/ABVX:1792500774938</loc>
    <lastmod>2026-10-20T12:52:54.938Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/ABVX/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Guggenheim Reiterates Buy on Abivax, Maintains $175 Price Target</image:title>
      <image:caption>Guggenheim analyst Yatin Suneja has reiterated a Buy rating on Abivax (NASDAQ: ABVX) and maintained a price target of $175 for the stock. This endorsement suggests confidence in the company&#39;s future performance.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/OXY:1792500745011</loc>
    <lastmod>2026-10-20T12:52:25.011Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.benzinga.com/files/images/story/2026/10/20/Milan--Italy---November-1--2017-Occident.jpg?width=250&amp;height=187</image:loc>
      <image:title>Occidental Petroleum To Rally Over 18%? Here Are 10 Top Analyst Forecasts For Tuesday</image:title>
      <image:caption>Susquehanna raised the price target for Occidental Petroleum Corp (NYSE: OXY) from $70 to $77, maintaining a Positive rating. The shares closed at $62.72 on Monday, indicating a potential upside of over 18%. This adjustment reflects a positive outlook from analysts amidst recent market evaluations.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/SMR:1792500704255</loc>
    <lastmod>2026-10-20T12:51:44.255Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.benzinga.com/files/images/story/2026/10/20/Nuscale-Power-Corporation-Logo-On-Mobile.jpg?width=250&amp;height=187</image:loc>
      <image:title>NuScale Stock Hits New Low After Barclays Downgrades It to Underweight, Cuts Target to $5</image:title>
      <image:caption>NuScale Power Corporation (NYSE: SMR) saw its stock drop 7.56% to $5.26 after Barclays downgraded it to Underweight from Equal Weight and reduced its price target from $11 to $5. The downgrade follows concerns over execution risks and delays in commercial development, with NuScale reporting only $75,000 in revenue last quarter against projected cash needs in the billions. Other analysts have also issued bearish ratings, with UBS lowering its target to $6 and RBC Capital adjusting it to $7, citing dilution concerns from a $750 million share offering.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/EQIX:1792500653793</loc>
    <lastmod>2026-10-20T12:50:53.793Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/EQIX/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Guggenheim Reiterates Buy on Equinix, Maintains $1235 Price Target</image:title>
      <image:caption>Guggenheim analyst Joseph Osha has reiterated a Buy rating on Equinix (NASDAQ: EQIX) and maintained a price target of $1235 for the stock. This reaffirmation indicates continued confidence in the company&#39;s performance and market position.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/SFST:1792500594409</loc>
    <lastmod>2026-10-20T12:49:54.409Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/SFST/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Southern First Bancshares Q3 EPS $1.30 Beats $1.25 Estimate, Sales $37.530M Beat $34.100M Estimate</image:title>
      <image:caption>Southern First Bancshares (NASDAQ: SFST) reported Q3 earnings of $1.30 per share, surpassing the $1.25 estimate by 4%, and marking a 21.5% increase from $1.07 per share in the same quarter last year. The company&#39;s sales reached $37.530 million, exceeding the $34.100 million estimate by 10.06%, and reflecting a 36.33% rise from $27.529 million in the previous year.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/WSM:1792500583905</loc>
    <lastmod>2026-10-20T12:49:43.905Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/WSM/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Evercore ISI Group Maintains In-Line on Williams-Sonoma, Raises Price Target to $255</image:title>
      <image:caption>Evercore ISI Group analyst Oliver Wintermantel has maintained an In-Line rating on Williams-Sonoma (NYSE: WSM) and raised the price target from $240 to $255. This adjustment reflects a positive outlook for the company&#39;s stock performance.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/ADRX:1792500545962</loc>
    <lastmod>2026-10-20T12:49:05.962Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/ADRX/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>JP Morgan Initiates Coverage On Adarx Pharmaceuticals with Overweight Rating, Announces Price Target of $38</image:title>
      <image:caption>JP Morgan analyst Tessa Romero has initiated coverage on Adarx Pharmaceuticals (NASDAQ: ADRX) with an Overweight rating. The firm has set a price target of $38 for the company&#39;s stock.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/RTX:1792500452475</loc>
    <lastmod>2026-10-20T12:47:32.475Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/RTX/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>RTX CEO Says International Demand Is Rising, Driven By Higher Defense Spending Across Europe, Asia-pacific &amp;amp; MENA, Including In Germany, Poland &amp;amp; Japan</image:title>
      <image:caption>RTX CEO reported an increase in international demand, primarily fueled by heightened defense spending in regions such as Europe, Asia-Pacific, and MENA, with notable growth in countries like Germany, Poland, and Japan. This trend suggests a positive outlook for the company&#39;s revenue and market position in the defense sector.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/NNVC:1792500449030</loc>
    <lastmod>2026-10-20T12:47:29.030Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/NNVC/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>NanoViricides Announces That NV-387 Successfully Demonstrated Strong Safety, Tolerability, And Toxicological Parameters In An Animal Model Study Involving Juvenile Mouse Pups</image:title>
      <image:caption>NanoViricides announced that its antiviral drug NV-387 demonstrated strong safety and tolerability in a juvenile mouse model study, paving the way for potential pediatric clinical trials. The drug is currently in Phase II trials for treating Ebola and Mpox in the Democratic Republic of Congo, with plans to include pediatric cohorts if successful. NV-387 has also received Orphan Drug and Rare Pediatric Disease designations for Measles, with potential for a Priority Review Voucher worth around $200 million if the program is successful. The study showed no adverse effects at the highest tested dose of 1,230 mg/kg, indicating a favorable safety profile for future pediatric use.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/INTA:1792500411427</loc>
    <lastmod>2026-10-20T12:46:51.427Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/INTA/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Carr, Riggs &amp;amp; Ingram M&amp;amp;A Advisors Taps Intapp DealCloud With Celeste As Its Platform For Relationship Management And Deal Tracking</image:title>
      <image:caption>Intapp (NASDAQ: INTA) announced that Carr, Riggs &amp; Ingram M&amp;A Advisors has chosen its DealCloud with Celeste platform for relationship management and deal tracking. Carr, Riggs &amp; Ingram M&amp;A Advisors, part of one of the largest accounting firms in the U.S., focuses on sell-side engagements in the middle market, emphasizing the need for efficient deal origination and tracking.</image:caption>
    </image:image>
  </url>
</urlset>